The Present and FutureState-of-the-Art ReviewThe Aging Cardiovascular System: Understanding It at the Cellular and Clinical Levels
Central Illustration
Key Words
Abbreviations and Acronyms
Cited by (0)
The present work was supported by the Swiss National Science Foundation (Drs. Lüscher and Camici) and the Alfred and Annemarie von Sick Grants for Translational and Clinical Research Cardiology and Oncology (Dr. Camici), an unrestricted research grant by Pfizer, Inc. (Dr. Lüscher), the Foundation for Cardiovascular Research–Zurich Heart House and the U.S. National Institutes of Health (RO1 HL080472), and from the RRM Charitable Fund (Dr. Libby). Drs. Paneni and Camici are recipients of a Sheikh Khalifa's Foundation Assistant Professorship at the Faculty of Medicine, University of Zurich. Dr. Libby has been an unpaid consultant for Amgen, AstraZeneca, Esperion Therapeutics, Ionis Pharmaceuticals, Kowa Pharmaceuticals, Merck & Co., Novartis, Pfizer, Sanofi-Regeneron, Takeda Pharmaceuticals, and XBiotech; served as a scientific advisory board member for Amgen, Athera Biotechnologies, Corvidia Therapeutics, DalCor Pharmaceuticals, Interleukin Genetics, Kowa Pharmaceuticals, Medimmune, and Novartis; and has received lab funding from Novartis. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.